Table 2.
Causes of death during follow-up, according to liver fibrosis stage
| Overall (n = 3474) | F0–F3 (n = 2713) | F4 (n = 761) | p-Value | |
|---|---|---|---|---|
| Death (n = 50) | 50 (1.4 %) | 34 (1.2 %) | 16 (2.1 %) | 0.082 |
| Causes | n =50 | n = 34 | n = 16 | |
| Liver-related | 15 (30) | 4 (11.7 %) | 11 (68.7) | <0.001 |
| Non-AIDS malignancies | 10 (19.2) | 6 (17.6 %) | 4 (25) | 0.588 |
| Systemic bacterial infection | 7 (13.4) | 7 (20.6 %) | 0 | 0.054 |
| Cardiovascular event | 6 (9.6) | 6 (17.6 %) | 0 | 0.116 |
| Abuse of toxic substances | 4 (7.6) | 3 (8.8 %) | 1 (6.3) | 0.792 |
| AIDS-related | 3 (5.7) | 3 (8.8 %) | 0 | 0.389 |
| Gastrointestinal bleeding* | 2 (3.8) | 2 (5.9 %) | 0 | 0.771 |
| End-stage renal disease | 2 (3.8) | 2 (5.9 %) | 0 | 0.771 |
| Suicide | 2 (3.8) | 1 (3.1 %) | 0 | 0.66 |
*Gastrointestinal bleeding does not include bleeding from esophageal varices